Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.40    -1.60 (-1.01%)
Bid:
156.20
Ask:
156.60
Spread: 0.40 (0.256%)
Market Cap: £893.79m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Pre-close trading update

17 Dec 2015 07:00

ELEMENTIS PLC - Pre-close trading update

ELEMENTIS PLC - Pre-close trading update

PR Newswire

London, December 16

17 December 2015

Elementis plc – pre-close trading updateElementis plc (ELM.L, the "Company" or the "Group"), the Global Specialty Chemicals Company, today issues a trading update ahead of its results for the full year ending 31 December 2015, which will be announced on 1 March 2016.Since we issued our Interim Management Statement on 30 October 2015, markets have continued to be challenging and earnings per share for the current year is now projected to be at the lower end of the range of market expectations. Due to the cash generative nature of the Group and our ongoing focus on cash management, it is still anticipated that the Group’s year end net cash balance will be higher than the prior year balance of $64.2 million.Looking towards 2016, management expects Specialty Products to make progress against the current year, based on its strong and diverse market positions, new product launches and resilient contribution margins.In Chromium, the business will continue to benefit from its North American business model, where our unique delivery systems provide a value added service to customers. Export sales from North America, however, are likely to remain under pressure due to the strong US dollar. In addition, operating profit in the current year has benefited from approximately $5 million of “one-time” items, relating to a legal settlement and property easements which will not be repeated in 2016. Consequently, operating profit in 2016 in our Chromium operations is expected to be lower than the current year.Strong cash flow generation will continue to be an important feature of the Group’s performance in 2016 and both businesses will benefit next year from the recently announced measured actions to reduce our cost base.ENDSEnquiries:

Elementis+ 44 (0) 207 067 2999
David Dutro, Chief ExecutiveBrian Taylorson, Finance Director
FTI Consulting
+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
13th Nov 20209:54 amRNSForm 8.5 (EPT/NON-RI) - Elementis plc
13th Nov 20209:51 amRNSForm 8.5 (EPT/RI) - Elementis plc
13th Nov 20209:47 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - ELEMENTIS PLC - Ordinary Shares
12th Nov 20209:39 amRNSResponse to Minerals Technologies Inc announcement
12th Nov 20207:51 amRNSStatement re Possible Offer
9th Nov 20204:55 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
26th Oct 20207:00 amRNSUpdate on 2020 AGM resolution vote
16th Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:40 pmRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSCovenant update
1st Sep 20202:22 pmRNSBlock listing Interim Review
28th Jul 20207:00 amRNSHalf-year Report
8th Jun 20204:28 pmRNSHolding(s) in Company
15th May 20201:08 pmRNSHolding(s) in Company
1st May 20209:56 amRNSTotal Voting Rights
29th Apr 202011:02 amRNSDirector Declaration
29th Apr 202010:49 amRNSResult of AGM
29th Apr 20207:00 amRNSAGM Trading Statement
28th Apr 202012:06 pmRNSDisclosure of rights attached to equity shares
21st Apr 20207:00 amRNSAGM update
8th Apr 202011:50 amRNSDirector/PDMR Shareholding
2nd Apr 20202:51 pmRNSHolding(s) in Company
1st Apr 20208:13 amRNSDirector Declaration
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change
21st Jan 20208:46 amPRNDirector Declaration
20th Jan 202010:54 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.